CHRONIC MYELOID LEUKAEMIA Flashcards

1
Q

what is chronic myeloid leukaemia

A

cancer of white blood cells characterised by uncontrolled growth of the myeloid cells in the bone marrow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

which chromosomal abnormality causes CML

A

philadelphia chromosome

translocation between 9 and 22 (BCR-ABL)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

how does the BCR-ABL mutation result in malignant growth

A

the gene is able to add phosphates to tyrosine residues (a tyrosine kinase) and this allows BCR-ABL to activate a cascade of proteins which control the cell cycle, speeding up cell division

it also inhibits DNA repair

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

how do patients generally present

A

asymptomatically, with an elevated WCC on routine blood test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

symptoms of CML include

A
upper abdominal pain
poor appetite 
low grade fever/night sweats 
gout 
increased susceptibility to infection 
SOB/fatigue 
easy brushing/petechiae/bleeding 
neurological deficits/visual disturbance
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

why does CML predispose to gout

A

increased cell turnover –> excess purines –> broken down to uric acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the three phases of CML

A

chronic phase
accelerated phase
blast crisis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what are features of the chronic phase

A

asymptomatic/mild symptoms

variable duration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what are the criteria of the accelerated phase

A

10-19% myeloblasts in blood or bone marrow

> 20% basophils in the blood or bone marrow

platelet count <100,00, unrelated to therapy

platelet count >1,000,000, unresponsive to therapy

cryogenic evolution with new abnormalities

increasing splenomegaly or WCC, unresponsive to therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what is blast crisis

A

final phase of CML, in which the disease behaves like an acute leukaemia, with rapid progression and short survival

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

how is blast crisis diagnosed

A

> 20% myeloblasts or lymphoblasts in blood or bone marrow

large clusters of blasts in the bone marrow on biopsy

development of chroma (solid focus of leukaemia outside bone marrow)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what does FBC show in CML

A

leukocytosis
increased EO and BA
differential WCC shows granulocytes at all stages of development
anaemia (normo/normo)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what does biochemistry show in CML

A

lactacte dehydrogenase is often raised

rate may be raised

U&Es are usually normal at presentations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what does peripheral blood film show in CML

A

all stages of granulocyte maturation

appearances similar to that of a bone marrow aspirate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

why is bone marrow aspirate necessary

A

to stage disease (% of blasts determines chronic vs accelerated vs blast crisis)

allows cryogenic sampling (Philadelphia chromosome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what methods are used to identify the Philadelphia chromosome

A

FISH

PCR for BCR-ABL gene

17
Q

what is the mainstay of management

A

tyrosine kinase inhibitors

18
Q

what is an example of a first line TKI

A

imatinib

19
Q

what is the target of imatinib

A

BCR-ABL

blocks ability to phosphorylate a tyrosine

20
Q

how is response to imatinib monitored

A

PCR testing for BCR-ABL

21
Q

what are examples of second generation TKIs

A

nilotinib

dasatinib

22
Q

what treatment options are there if there is no response to drug therapy

A

bone marrow transplantation

23
Q

which patients are suitable for bone marrow transplantation

A

younger, otherwise healthy patients